Clinical Trial Update: Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist [NA]

View source ↗

Summary

A clinical trial evaluating a GIP receptor antagonist to inhibit the endogenous GIP response in glucose metabolism disorders has completed (NCT03133741). No res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Metabolism Disorders

Drugs mentioned

• GIP receptor antagonist

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Glucose Metabolism Disorders | NA | Status: COMPLETED